Using targeted proteomics, Martinez-Garcia and colleagues explored the levels of 52 proteins in the fluid fraction of uterine aspirates acquired from 69 women with endometrial cancer and 47 controls and found that the biomarker panel combining MMP9 and KPYM detected endometrial cancer with 94% sensitivity and 87% specificity.37 This evidence concerns the gene MMP9 and endometrial cancer.